Background: Hyphaene thebaica L. Mart. (Doum-palm), rich in total phenolics content, is known for its medicinal value in the treatment of several health conditions, such as hypertension, and diabetes mellitus. Aim of the Study: To investigate the hypoglycaemic activity of the dichloromethane, ethyl acetate, and aqueous fractions from doum palm leaves. Then, to characterize the metabolic profile of the most active fraction by LC-HR-MS/MS analysis to detect the responsible metabolites for this activity. Material and Methods: The present study examined the in vitro inhibitory effect of the extract fractions from Doum Palm Leaves at concentrations ranging from 7.81 to 1000.00 μg/ml on α-glucosidase activity, an enzyme responsible for carbohydrate-hydrolysis to monosaccharides and intestinal glucose absorption. Metabolic profiling for the dichloromethane fraction was obtained with LC-HR-MS/MS. Results: The dichloromethane (DCM) fraction inhibited α-glucosidase activity in vitro with an IC50 of 52.40 μg/ml. Twenty-three compounds were identified in the DCM fraction by LC-HR-MS/MS analysis. Most of them were reported for their potential antidiabetic activity. Nevertheless, the III-DCM subfraction (IC50 3.79 ± 0.17 μg/ml) and the IV-DCM subfraction (IC50 5.13 ± 0.24 μg/ml) had the best inhibitory activity against α-glucosidase compared with acarbose (IC50 2.33 ± 0.11 μg/ml). Conclusions: The results support the use of these fractions obtained from Doum palm leaves to effectively inhibit a crucial enzyme linked to type 2 diabetes and suppress carbohydrate absorption from intestine, and thereby reducing the postprandial increase of blood glucose
Research Date
Research Department
Research Journal
Bulletin of Pharmaceutical Sciences
Research Vol
45
Research Website
https://bpsa.journals.ekb.eg/article_239375.html
Research Year
2022
Research Member
Research_Pages
163-176
Research Abstract